Dimeric-(−)-epigallocatechin-3-gallate inhibits the proliferation of lung cancer cells by inhibiting the EGFR signaling pathwayXiuli Sun, Cheng‐Ting Zi, Zemin Xiang et al.|Chemico-Biological Interactions|2022Cited by 17
Novel Perbutyrylated Glucose Derivatives of (–)-Epigallocatechin-3-Gallate Inhibit Cancer Cells Proliferation by Decreasing Phosphorylation of the EGFR: Synthesis, Cytotoxicity, and Molecular DockingYa Wang, Jun Sheng, Xiaojing Shen et al.|Molecules|2021Cited by 13
KEYNOTE-042最終解析:ファーストラインPD-L1陽性局所進行/転移NSCLCにおけるペムブロリズマズvs化学療法Kubota Kaoru, G. Lopes, Vichien Srimuninnimit et al.|日本臨床腫瘍学会学術集会(CD-ROM)|2019Cited by 0
KEYNOTE-042 Final Analysis: Pembrolizumab vs Chemotherapy in First-Line PD-L1-Positive Locally Advanced/Metastatic NSCLCKubota Kaoru, G. Lopes, Surekha Tony et al.|日本臨床腫瘍学会学術集会(CD-ROM)|2019Cited by 0